Does risperidone (Risperdal) cause a decrease in serum sodium?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Risperidone (Risperdal) Cause Hyponatremia?

Yes, risperidone can cause hyponatremia (decreased serum sodium), though this is an uncommon but serious adverse effect that requires clinical vigilance.

Evidence for Sodium Disturbances

The evidence clearly documents risperidone-associated hyponatremia through multiple case reports and clinical observations. A 55-year-old patient developed severe hyponatremia attributed to long-acting injectable risperidone that failed to respond to standard water restriction and hypertonic saline 1. More dramatically, a 40-year-old woman on high-dose risperidone (6 mg/day) developed syndrome of inappropriate antidiuretic hormone secretion (SIADH) with serum sodium dropping to 106 mmol/L, presenting initially with tonic-clonic seizures 2. The SIADH resolved after discontinuing risperidone and administering hypertonic saline 2.

Mechanism and Risk Factors

The mechanism likely involves risperidone's high affinity for 5-HT2A and dopamine D2 receptors, which can trigger SIADH 2. This represents a class effect seen with second-generation antipsychotics, though the specific risk profile varies among agents 3.

Key risk factors include:

  • Higher doses (particularly ≥6 mg/day)
  • Older age and frailty
  • Renal impairment (which doubles active moiety concentrations when GFR <60 mL/min) 4
  • Concurrent medications affecting sodium balance

Clinical Monitoring Recommendations

Monitor serum sodium levels:

  • At baseline before initiating risperidone
  • Within the first 2-4 weeks of treatment (when most adverse effects emerge) 5
  • When increasing doses, especially above 3 mg/day
  • If patients develop new neurological symptoms (confusion, seizures, lethargy)

The FDA label does not specifically list hyponatremia as a labeled adverse effect 6, but clinical practice guidelines for other antipsychotics acknowledge electrolyte disturbances as complications requiring monitoring 7, 8.

Management Approach

If hyponatremia develops:

  1. Assess severity: Serum sodium <125 mmol/L requires immediate intervention
  2. Stop or reduce risperidone if sodium <120-125 mmol/L
  3. Fluid restriction to 1-1.5 L/day for severe symptomatic hyponatremia 9
  4. Hypertonic saline (3%) reserved for severely symptomatic acute hyponatremia with slow correction 9
  5. Consider alternative antipsychotic with lower SIADH risk (e.g., aripiprazole) if risperidone must be discontinued

Important Caveats

  • Hyponatremia may present insidiously, with seizures as the first manifestation 2
  • Patients with schizophrenia may display atypical features of medical illness, making routine laboratory monitoring essential 2
  • The condition can be "latent" without early warning signs beyond subtle neurological changes
  • Standard treatment protocols (water restriction, hypertonic saline) may fail with long-acting injectable formulations, requiring prolonged management 1

Bottom line: While not among the most common risperidone adverse effects (weight gain, extrapyramidal symptoms, sedation remain more frequent 10), hyponatremia represents a potentially life-threatening complication requiring baseline and periodic sodium monitoring, particularly in elderly patients, those on higher doses, or those with renal impairment.

Related Questions

What is the recommended starting dose of risperidone for treating irritability?
How can I simplify the risperidone dosing regimen for an 8‑year‑old child currently taking 0.5 mg twice daily plus an additional 0.25 mg twice daily?
When is risperidone indicated, and what are the recommended dosing, monitoring, and contraindications for its use in adults and pediatric patients?
What is the recommended starting dose and titration schedule for risperidone in an adult patient, specifically comparing 0.25 mg twice daily versus 0.5 mg twice daily?
What is the most likely primary diagnosis for a 22‑year‑old woman with a two‑year history of persistent psychotic symptoms (delusional beliefs, tactile hallucinations, paranoia) and marked mood instability with manic/hypomanic and depressive episodes that are refractory to risperidone?
Should a 22-year-old woman with recent 13% weight loss, post‑prandial nausea, irregular periods, a new sexual partner, and recent initiation of the contraceptive injection (depot medroxyprogesterone acetate) undergo an urgent transvaginal ultrasound and be screened with a cervical smear?
What ICD‑10‑CM code should be used for a 57‑year‑old man with lower abdominal pain relieved by urination due to bladder outlet obstruction from benign prostatic hyperplasia, and is there a secondary code for urinary retention?
What is the appropriate management for a tattoo infection, including antibiotic selection and wound care?
Does venlafaxine cause acute dystonia?
A patient with anxiety and panic disorder who was started on Augmentin (amoxicillin‑clavulanate) for a tooth abscess now has chest tightness and shortness of breath—should she discontinue the antibiotic and seek emergency care for a possible allergic reaction?
In a 14-year-old male on guanfacine 2 mg at bedtime who is disrespectful, uses profanity toward his teacher, and shows no interest in school, what additional pharmacologic treatment can be recommended?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.